List of Tables
Table 1: Number of Products under Development for Gastroenteritis
Table 2: Number of Products under Development by Companies, Gastroenteritis
Table 3: Number of Products under Development by Universities/Institutes, Gastroenteritis
Table 4: Products under Development by Companies, Gastroenteritis
Table 5: Products under Development by Universities/Institutes, Gastroenteritis
Table 6: Number of Products under Development for Enterocolitis
Table 7: Number of Products under Development by Companies, Enterocolitis
Table 8: Number of Products under Development by Universities/Institutes, Enterocolitis
Table 9: Products under Development by Companies, Enterocolitis
Table 10: Products under Development by Universities/Institutes, Enterocolitis
Table 11: Number of Products under Development for Gastritis
Table 12: Number of Products under Development by Companies, Gastritis
Table 13: Products under Development by Companies, Gastritis
Table 14: Number of Products under Development for Peritonitis
Table 15: Number of Products under Development by Companies, Peritonitis
Table 16: Products under Development by Companies, Peritonitis
Table 17: Number of Products by Stage and Target, Gastroenteritis
Table 18: Number of Products by Stage and Mechanism of Action, Gastroenteritis
Table 19: Number of Products by Stage and Route of Administration, Gastroenteritis
Table 20: Number of Products by Stage and Molecule Type, Gastroenteritis
Table 21: Number of Products by Stage and Target, Enterocolitis
Table 22: Number of Products by Stage and Mechanism of Action, Enterocolitis
Table 23: Number of Products by Stage and Route of Administration, Enterocolitis
Table 24: Number of Products by Stage and Molecule Type, Enterocolitis
Table 25: Number of Products by Stage and Target, Gastritis
Table 26: Number of Products by Stage and Mechanism of Action, Gastritis
Table 27: Number of Products by Stage and Route of Administration, Gastritis
Table 28: Number of Products by Stage and Molecule Type, Gastritis
Table 29: Number of Products by Stage and Target, Peritonitis
Table 30: Number of Products by Stage and Mechanism of Action, Peritonitis
Table 31: Number of Products by Stage and Route of Administration, Peritonitis
Table 32: Number of Products by Stage and Molecule Type, Peritonitis
Table 33: Gastroenteritis – Pipeline by Kyowa Hakko Kirin Co Ltd
Table 34: Gastroenteritis – Pipeline by Medicago Inc
Table 35: Gastroenteritis – Pipeline by Ology Bioservices Inc
Table 36: Gastroenteritis – Pipeline by RedHill Biopharma Ltd
Table 37: Gastroenteritis – Pipeline by Regeneron Pharmaceuticals Inc
Table 38: Gastroenteritis – Pipeline by Takeda Pharmaceutical Co Ltd
Table 39: Gastroenteritis – Pipeline by UMN Pharma Inc
Table 40: Gastroenteritis – Pipeline by Vaxart Inc
Table 41: Enterocolitis – Pipeline by Avexegen Therapeutics Inc
Table 42: Enterocolitis – Pipeline by Infant Bacterial Therapeutics AB
Table 43: Enterocolitis – Pipeline by Leadiant Biosciences Inc
Table 44: Enterocolitis – Pipeline by ProMetic Life Sciences Inc
Table 45: Gastritis – Pipeline by BCWorld Pharm Co Ltd
Table 46: Gastritis – Pipeline by Daewon Pharm Co Ltd
Table 47: Gastritis – Pipeline by Daewoong Pharmaceutical Co Ltd
Table 48: Gastritis – Pipeline by Kyowa Hakko Kirin Co Ltd
Table 49: Gastritis – Pipeline by Recce Ltd
Table 50: Gastritis – Pipeline by RedHill Biopharma Ltd
Table 51: Gastritis – Pipeline by Sequella Inc
Table 52: Peritonitis – Pipeline by GlaxoSmithKline Plc
Table 53: Peritonitis – Pipeline by Nosopharm SAS
Table 54: Peritonitis – Pipeline by Oncodesign SA
Table 55: Peritonitis – Pipeline by SynAct Pharma AB
Table 56: Gastroenteritis – Dormant Projects
Table 57: Enterocolitis – Dormant Projects
Table 58: Gastritis – Dormant Projects
Table 59: Peritonitis – Dormant Projects
Table 60: Gastroenteritis – Discontinued Products